The sRNA-encoded peptide TimP rewires the Escherichia coli envelope via LamB to sensitize bacteria to polymyxins
Drug Resistance Updates · 2026
DOI: 10.1016/j.drup.2026.101406 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Resistance Updates, 2026. Verfasst von Hyejin Cho und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Chemistry Institute for Functional Materials, Pusan National University, Busan 46241, Republic of Korea. Hauptthemen laut MEDLINE: Escherichia coli, Anti-Bacterial Agents, Polymyxins, Porins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 99 Literaturangaben. Gefördert von: National Research Foundation of Korea, National Institute of Genetics, Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
The rise of multidrug-resistant (MDR) Escherichia coli has marginalized last-line polymyxins (PMs) owing to evolving resistance and narrow therapeutic windows. Revitalizing these agents requires the identification of novel regulatory circuits governing the integrity of the gram-negative envelope. In this study, we identified a stress-responsive peptide TimP and demonstrated that its intracellular overexpression (TimP+), a synthetic variant (FT-Pep), and biogenic TimP+-derived extracellular vesicles (TimP EVs) exhibited equivalent functionality in sensitizing E. coli to PMs, consistently inducing PM-mediated phenotypes. Mechanistically, TimP in E. coli initiates coordinated envelope remodeling by interacting with porin LamB via a specific N21TimP-R134LamB molecular interface. Furthermore, the TimP-TimR/TimP-LamB interaction is functionally conserved in both E. coli and Salmonella. Pharmacokinetic profiling and spatiotemporal imaging of FT-Pep revealed a predictable physiological disposition across major organs and gradual systemic clearance over 24 h, with no evidence of pathological sequestration. Hepatic and immunological assessments confirmed that FT-Pep or TimP EVs were systemically inert, with serum pro-inflammatory markers and liver enzymes remaining within baseline physiological ranges. Exploiting these beneficial effects, we engineered polymyxin B (PMB)@TimP EVs, which exhibited enhanced bactericidal activity, improved pH stability, and negligible mammalian cytotoxicity compared with free PMB. In a murine sepsis model, PMB@TimP EVs demonstrated clear in vivo efficacy at an equivalent dose, maintaining survival when free PMB failed. Collectively, this study identified TimP as a conserved target and demonstrated a Trojan-horse drug delivery system capable of restoring the efficacy of PM against MDR gram-negative pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Chemistry Institute for Functional Materials, Pusan National University, Busan 46241, Republic of Korea.
- Bionanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea; School of Pharmacy, Sungkyunkwan University (SKKU), Suwon…
- Bionanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea.
- Department of Chemistry and Chemistry Institute for Functional Materials, Pusan National University, Busan 46241, Republic of Korea. Electronic address: kwangsun.kim@pusan.ac.kr.
Förderung
- National Research Foundation of Korea
- National Institute of Genetics
- Ministry of Science and ICT, South Korea
Zitieren
APA
Cho, H., Jung, J., Yi, S., & Kim, K. S. (2026). The sRNA-encoded peptide TimP rewires the Escherichia coli envelope via LamB to sensitize bacteria to polymyxins. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2026.101406
Vancouver
Cho H, Jung J, Yi S, Kim KS. The sRNA-encoded peptide TimP rewires the Escherichia coli envelope via LamB to sensitize bacteria to polymyxins. Drug Resistance Updates. 2026. doi:10.1016/j.drup.2026.101406
BibTeX
@article{Cho2026,
author = {Cho, Hyejin and Jung, Juyeon and Yi, Soyeon and Kim, Kwang-Sun},
title = {The sRNA-encoded peptide TimP rewires the Escherichia coli envelope via LamB to sensitize bacteria to polymyxins},
journal = {Drug Resistance Updates},
year = {2026},
doi = {10.1016/j.drup.2026.101406}
}
EUVIMED